Andrew Carruthers

North West Fund for Biomedical Investment Committee member


Andrew is responsible for managing relationships with all the stakeholders involved with the activities of the SPARK group, including shareholders, limited partners, universities or VCT boards. He also sits on the board of a number of portfolio companies, including DEM, Antenova, Aspex and Perpetuum, leading SPARK’s active participation in the development of these companies.

He was previously a director of NewMedia Investors where he led on capital raising and corporate finance for a range of technology businesses including Prior to that Andrew was involved in the operational management of technology and finance as a director or founder of online information, TV and digital distribution companies in the US and UK.

Andrew qualified as a chartered accountant with KPMG. He was appointed to the board of SPARK Ventures in September 1999.